Skip to main content

Table 3 I.p. application of trAb anti-Her2/neu and side effects

From: Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosis

Pat. TrAb anti Her2/neu therapy (μg i.p./day) Cumulative dose Side effects
  μg Day μg Day μg day (μg)  
D 10 1 40 4 80 8 130 Fever (1)
E 10 1 40 6 80 8 130 Fever (1); abdominal pain (2)
  1. Individual schedule of trAb therapy and side effects according to the National Cancer Institute (NCI) common toxicity criteria.